Try searching for...
Dr Marcus Dreosti
BSc, Hons LLB, MBBS (Hons) FRANZCR
Chief Medical Officer, GenesisCare Australia
For patients/carers
For doctors
BSc, Hons LLB, MBBS (Hons) FRANZCR
Chief Medical Officer, GenesisCare Australia
Locations
Clinical interests
- Prostate cancer
- Breast cancer
- Gastrointestinal cancer
- Gynaecological cancer
Languages
Fluent
- English
Biography
Clinical interests include breast, prostate, gastrointestinal & gynaecological.
Dr Marcus Dreosti is a Senior Radiation Oncologist at GenesisCare South Australia and the Chief Medical Officer of GenesisCare Australia. Dr Dreosti graduated with Honours degrees in both Law and Medicine from Adelaide and Flinders Universities respectively. He undertook specialist training in Radiation Oncology at St Vincent’s Hospital, Sydney and the Royal Adelaide Hospital.
He completed Clinical Fellowships in Singapore and Darwin before returning to Sydney to assume the role of Staff Specialist at Liverpool and Macarthur Cancer Centres – a sub-specialised tertiary cancer department. During this time, he focused on the treatment of breast cancer and, further was part of the team who introduced a stereotactic radiotherapy program to the centres for specific tumour types. In addition, he acted as a conjoint lecturer at the University of Western Sydney (UWS) Medical School, where he taught oncology and clinical skills to medical students.
Dr Dreosti then moved home to Adelaide where he is now a Senior Radiation Oncologist at GenesisCare, Medical Director in South Australia and is the Chief Medical Officer of GenesisCare Australia.
His clinical interests include breast, prostate, gastrointestinal, and gynaecological cancers.
Dr Dreosti is an Examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) Registrars undertaking their final specialist examinations and is an Executive Director of the Australian Society of Breast Disease. He is also a regular presenter at medical conferences.
More information
- Royal Australian and New Zealand College of Radiologists (RANZCR)
- European SocieTy for Radiotherapy and Oncology (ESTRO)
- American Society for Radiation Oncology (ASTRO)
- Australian and New Zealand Head and Neck Cancer Society (ANZHNS)
- Australasian Society for Breast Disease (ASBD)
- Pryor, D., Turner, S., Tai, K.-H., Tang, C., Sasso, G., Dreosti, M., Woo, H. H., Wilton, L., & Martin, J. M. (2018). Moderate hypofractionation for prostate cancer: A user’s guide. Journal of Medical Imaging and Radiation Oncology, 62(2), 232-239. https://doi.org/10.1111/1754-9485.12703
- Neville, K., Dreosti, M., Blakey, D., Latham, M., Izard, M. A., Young, S., Graham, G., & O’Brien, P. (2020). Adoption of hypofractionated radiation therapy for early breast cancer in private practice: The Gen…. Journal of Medical Imaging & Radiation Oncology, 64(1), 127-133. https://doi.org/10.1111/1754-9485.12964
- Hoyne, C., Dreosti, M., Shakeshaft, J., & Baxi, S. (2017). Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective s…. Journal of Medical Radiation Sciences, 64(2), 125-130. https://doi.org/10.1002/jmrs.203
- Nguyen, K., Mackenzie, P., Allen, A., Dreosti, M., Morgia, M., Zissiadis, Y., Lamoury, G., & Windsor, A. (2017). Breast Interest Group Faculty of Radiation Oncology: Australian and New Zealand patterns of practic…. Journal of Medical Imaging & Radiation Oncology, 61(4), 508-516. https://doi.org/10.1111/1754-9485.12566
- Roos, D. E., Dreosti, M. V., James, C. L., & Hissaria, P. (2018). Radiotherapy for parotid IgG4-related disease. Journal of Medical Radiation Sciences, 66(1), 66–69. https://doi.org/10.1002/JMRS.304
